Insmed (INSM) Enterprise Value (2010 - 2026)

Insmed has reported Enterprise Value for 17 years, with the latest figure at $22.1 billion in Q2 2026.

• On a quarterly basis, Enterprise Value rose 14.05% year-over-year to $22.1 billion in Q2 2026; TTM through Jun 2026 was $22.1 billion, a 14.05% increase from a year earlier, with the FY2025 full-year figure at $35.9 billion, up 227.46% from the prior year.
• Enterprise Value was $22.1 billion for Q2 2026 at Insmed, down from $34.2 billion in the prior quarter.
• The five-year high for Enterprise Value was $35.9 billion in Q4 2025, with the low at $1.3 billion in Q1 2023.
• Average Enterprise Value over 5 years is $11.5 billion, with a median of $6.9 billion recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Enterprise Value slumped 38.81% in 2023, then jumped 373.67% in 2024.
• Over 5 years, Enterprise Value stood at $1.6 billion in 2022, then surged by 143.61% to $3.8 billion in 2023, then soared by 187.77% to $11.0 billion in 2024, then jumped by 227.46% to $35.9 billion in 2025, then plunged by 38.33% to $22.1 billion in 2026.
• The last three Enterprise Value figures came in at $22.1 billion (Q2 2026), $34.2 billion (Q1 2026), and $35.9 billion (Q4 2025), per Business Quant data.